North America Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Non-Melanoma and Melanoma), By Test Type (Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others), ByEnd-use, By Country and Growth Forecast, 2024 - 2031

The North America Skin Cancer Diagnostics Market would witness market growth of 4.8% CAGR during the forecast period (2024-2031).

The US market dominated the North America Skin Cancer Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,355 million by 2031. The Canada market is experiencing a CAGR of 7% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 6.1% during (2024 - 2031).

Technological advancements have profoundly impacted the skin cancer diagnostics market. The accuracy and efficacy of skin cancer detection have been improved by advancements in molecular diagnostics, artificial intelligence (AI), and imaging technologies.

Moreover, dermatoscopy, a non-invasive technique that uses a handheld device to examine skin lesions, has become a standard tool in dermatological practice. Confocal microscopy and high-frequency ultrasound offer detailed imaging at a cellular level, allowing for precise characterization of suspicious lesions.

In North America, the prevalence of skin cancer, particularly melanoma, is consistently increasing. This fuels the demand for accurate and efficient diagnostic tools. The United States has seen a significant rise in skin cancer cases, particularly melanoma, which is one of the most common types of cancer in the country. According to the American Cancer Society, about 100,640 new cases of melanoma are expected to be diagnosed in 2024, with approximately 8,290 deaths expected from the disease Factors contributing to the increased demand for skin cancer diagnostics include higher awareness and screening, increased exposure to ultraviolet (UV) radiation, and indoor tanning practices.

Free Valuable Insights: The Skin Cancer Diagnostics Market is Predict to reach USD 12.8 Billion by 2031, at a CAGR of 5.3%

Based on Type, the market is segmented into Non-Melanoma and Melanoma. Based on Test Type, the market is segmented into Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others. Based on End-use, the market is segmented into Hospital & Clinics, Laboratories, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Castle Biosciences, Inc.
• Bausch Health Companies, Inc. (DermTech, Inc.)
• Canfield Scientific, Inc.
• DermaSensor, Inc.
• F.Hoffmann-La Roche Ltd.
• NeoGenomics, Inc.
• Quest Diagnostics Incorporated.
• Digital Diagnostics, Inc. (3Derm Systems, Inc.)
• FotoFinder Systems GmbH
• Veriskin Inc

North America Skin Cancer Diagnostics Market Report Segmentation

By Type

• Non-Melanoma
• Melanoma

By Test Type

• Skin Biopsy
• Imaging Tests
• Dermatoscopy
• Lymph Node Biopsy
• Others

By End-use

• Hospital & Clinics
• Laboratories
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Skin Cancer Diagnostics Market, by Type
1.4.2 North America Skin Cancer Diagnostics Market, by Test Type
1.4.3 North America Skin Cancer Diagnostics Market, by End-use
1.4.4 North America Skin Cancer Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Skin Cancer Diagnostics Market by Type
4.1 North America Non-Melanoma Market by Country
4.2 North America Melanoma Market by Country

Chapter 5. North America Skin Cancer Diagnostics Market by Test Type
5.1 North America Skin Biopsy Market by Country
5.2 North America Imaging Tests Market by Country
5.3 North America Dermatoscopy Market by Country
5.4 North America Lymph Node Biopsy Market by Country
5.5 North America Others Market by Country

Chapter 6. North America Skin Cancer Diagnostics Market by End-use
6.1 North America Hospital & Clinics Market by Country
6.2 North America Laboratories Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Skin Cancer Diagnostics Market by Country
7.1 US Skin Cancer Diagnostics Market
7.1.1 US Skin Cancer Diagnostics Market by Type
7.1.2 US Skin Cancer Diagnostics Market by Test Type
7.1.3 US Skin Cancer Diagnostics Market by End-use
7.2 Canada Skin Cancer Diagnostics Market
7.2.1 Canada Skin Cancer Diagnostics Market by Type
7.2.2 Canada Skin Cancer Diagnostics Market by Test Type
7.2.3 Canada Skin Cancer Diagnostics Market by End-use
7.3 Mexico Skin Cancer Diagnostics Market
7.3.1 Mexico Skin Cancer Diagnostics Market by Type
7.3.2 Mexico Skin Cancer Diagnostics Market by Test Type
7.3.3 Mexico Skin Cancer Diagnostics Market by End-use
7.4 Rest of North America Skin Cancer Diagnostics Market
7.4.1 Rest of North America Skin Cancer Diagnostics Market by Type
7.4.2 Rest of North America Skin Cancer Diagnostics Market by Test Type
7.4.3 Rest of North America Skin Cancer Diagnostics Market by End-use

Chapter 8. Company Profiles
8.1 Castle Biosciences, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.7.4.2 Acquisition and Mergers:
8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. VERISKIN INC.
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 North America Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 North America Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 North America Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 4 North America Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 5 North America Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 10 North America Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 11 North America Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 22 North America Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 23 North America Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 31 US Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 32 US Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 33 US Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 34 US Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 35 US Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 36 US Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 37 US Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 38 US Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 39 Canada Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 40 Canada Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 41 Canada Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 42 Canada Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 43 Canada Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 44 Canada Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 45 Canada Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 46 Canada Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 47 Mexico Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 48 Mexico Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 49 Mexico Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 50 Mexico Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 51 Mexico Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 52 Mexico Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 53 Mexico Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 54 Mexico Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 55 Rest of North America Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 56 Rest of North America Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 57 Rest of North America Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 58 Rest of North America Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 59 Rest of North America Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 60 Rest of North America Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 61 Rest of North America Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 62 Rest of North America Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 63 Key Information – Castle Biosciences, Inc.
TABLE 64 key information – Bausch Health Companies, Inc.
TABLE 65 Key Information – Canfield Scientific, Inc.
TABLE 66 Key Information – Dermasensor, Inc.
TABLE 67 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 68 Key Information – neogenomics, inc.
TABLE 69 Key information – Quest Diagnostics Incorporated
TABLE 70 Key Information – Digital Diagnostics, Inc.
TABLE 71 Key Information – FotoFinder Systems GmbH
TABLE 72 Key Information – Veriskin Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Skin Cancer Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Skin Cancer Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Skin Cancer Diagnostics Market
FIG 5 North America Skin Cancer Diagnostics Market share by Type, 2023
FIG 6 North America Skin Cancer Diagnostics Market share by Type, 2031
FIG 7 North America Skin Cancer Diagnostics Market by Type, 2020 - 2031, USD Million
FIG 8 North America Skin Cancer Diagnostics Market share by Test Type, 2023
FIG 9 North America Skin Cancer Diagnostics Market share by Test Type, 2031
FIG 10 North America Skin Cancer Diagnostics Market by Test Type, 2020 - 2031, USD Million
FIG 11 North America Skin Cancer Diagnostics Market share by End-use, 2023
FIG 12 North America Skin Cancer Diagnostics Market share by End-use, 2031
FIG 13 North America Skin Cancer Diagnostics Market by End-use, 2020 - 2031, USD Million
FIG 14 North America Skin Cancer Diagnostics Market share by Country, 2023
FIG 15 North America Skin Cancer Diagnostics Market share by Country, 2031
FIG 16 North America Skin Cancer Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT analysis: Castle Biosciences, Inc.
FIG 18 SWOT Analysis: Bausch Health Companies, Inc.
FIG 19 SWOT Analysis: Canfield Scientific, Inc.
FIG 20 SWOT analysis: DermaSensor, Inc.
FIG 21 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: Neogenomics, Inc.
FIG 23 SWOT Analysis: Quest Diagnostics Incorporated
FIG 24 SWOT Analysis: FotoFinder Systems GmbH
FIG 25 SWOT analysis: VERISKIN INC.